title: Use of rFVIIa in two children presenting major bleeding not controlled by the usual treatments before emergent surgery.
authors.forename: Eliane
authors.initials: E
authors.lastname: Guyot
authors.forename: Aude
authors.initials: A
authors.lastname: Carillion
authors.forename: Marie-Laurence
authors.initials: ML
authors.lastname: Poli-Mérol
authors.forename: Isabelle
authors.initials: I
authors.lastname: Ferrand
authors.forename: Philippe
authors.initials: P
authors.lastname: Chauvet
authors.forename: Philippe
authors.initials: P
authors.lastname: Nguyen
authors.forename: Jean-Marc
authors.initials: JM
authors.lastname: Malinovsky
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use; D002528:Cerebellar Neoplasms / Q000150:complications / Q000601:surgery; D002648:Child; D004750:Enteral Nutrition; D015942:Factor VIIa / Q000627:therapeutic use*; D005774:Gastrostomy; D006391:Hemangioma / Q000150:complications / Q000601:surgery; D006493:Heparin / Q000009:adverse effects / Q000627:therapeutic use; D006706:Homeostasis / Q000187:drug effects; D006801:Humans; D007431:Intraoperative Complications / Q000188:drug therapy*; D010535:Laparoscopy; D008297:Male; D008527:Medulloblastoma / Q000150:complications / Q000601:surgery; D011183:Postoperative Complications / Q000601:surgery; D011994:Recombinant Proteins / Q000627:therapeutic use; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D013160:Splenic Neoplasms / Q000150:complications / Q000601:surgery
chemical_list: D000925:Anticoagulants; D011994:Recombinant Proteins; D006493:Heparin; D015942:Factor VIIa